Activin, TGF-beta and menin in pituitary tumorigenesis
- PMID: 20175454
- DOI: 10.1007/978-1-4419-1664-8_7
Activin, TGF-beta and menin in pituitary tumorigenesis
Abstract
Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.
Similar articles
-
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin.Mol Endocrinol. 2004 Jun;18(6):1558-69. doi: 10.1210/me.2003-0470. Epub 2004 Mar 18. Mol Endocrinol. 2004. PMID: 15031321
-
Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.J Clin Endocrinol Metab. 1996 Feb;81(2):783-90. doi: 10.1210/jcem.81.2.8636304. J Clin Endocrinol Metab. 1996. PMID: 8636304
-
Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.Am J Pathol. 1997 Aug;151(2):509-19. Am J Pathol. 1997. PMID: 9250163 Free PMC article.
-
Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.Horm Metab Res. 2005 Jun;37(6):375-9. doi: 10.1055/s-2005-870152. Horm Metab Res. 2005. PMID: 16001330 Review.
-
Pituitary prolactin-secreting tumor formation: recent developments.Biol Signals Recept. 2000 Jan-Feb;9(1):1-20. doi: 10.1159/000014618. Biol Signals Recept. 2000. PMID: 10686432 Review.
Cited by
-
Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.Cells. 2024 Jun 4;13(11):973. doi: 10.3390/cells13110973. Cells. 2024. PMID: 38891107 Free PMC article.
-
SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.J Oncol. 2022 Oct 14;2022:4272525. doi: 10.1155/2022/4272525. eCollection 2022. J Oncol. 2022. Retraction in: J Oncol. 2023 Jul 12;2023:9813986. doi: 10.1155/2023/9813986. PMID: 36276274 Free PMC article. Retracted.
-
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.Pituitary. 2011 Jun;14(2):112-24. doi: 10.1007/s11102-010-0268-x. Pituitary. 2011. PMID: 21063788
-
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues.Cancer Cell Int. 2023 Feb 11;23(1):25. doi: 10.1186/s12935-023-02863-4. Cancer Cell Int. 2023. PMID: 36774501 Free PMC article.
-
The Local Control of the Pituitary by Activin Signaling and Modulation.Open Neuroendocrinol J. 2011 Jan 1;4:90-101. doi: 10.2174/1876528901104010090. Open Neuroendocrinol J. 2011. PMID: 21927629 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical